Views & Analysis JPM: Four ways FDA is seeking to buoy gene therapy On the outskirts of the JP Morgan Healthcare Conference today, FDA's Dr Peter Marks discussed how to get more gene therapies approved in 2024.
News Isomorphic signs up Lilly, Novartis for $3bn AI drug hunt Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma pa
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.